1. Home
  2. PSNL vs VALU Comparison

PSNL vs VALU Comparison

Compare PSNL & VALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • VALU
  • Stock Information
  • Founded
  • PSNL 2011
  • VALU 1931
  • Country
  • PSNL United States
  • VALU United States
  • Employees
  • PSNL N/A
  • VALU N/A
  • Industry
  • PSNL Medical Specialities
  • VALU Investment Managers
  • Sector
  • PSNL Health Care
  • VALU Finance
  • Exchange
  • PSNL Nasdaq
  • VALU Nasdaq
  • Market Cap
  • PSNL 460.7M
  • VALU 510.6M
  • IPO Year
  • PSNL 2019
  • VALU N/A
  • Fundamental
  • Price
  • PSNL $4.89
  • VALU $45.90
  • Analyst Decision
  • PSNL Strong Buy
  • VALU
  • Analyst Count
  • PSNL 4
  • VALU 0
  • Target Price
  • PSNL $8.56
  • VALU N/A
  • AVG Volume (30 Days)
  • PSNL 1.5M
  • VALU 6.8K
  • Earning Date
  • PSNL 02-26-2025
  • VALU 03-14-2025
  • Dividend Yield
  • PSNL N/A
  • VALU 2.61%
  • EPS Growth
  • PSNL N/A
  • VALU 26.35
  • EPS
  • PSNL N/A
  • VALU 2.36
  • Revenue
  • PSNL $87,489,000.00
  • VALU $35,859,000.00
  • Revenue This Year
  • PSNL $15.76
  • VALU N/A
  • Revenue Next Year
  • PSNL $4.90
  • VALU N/A
  • P/E Ratio
  • PSNL N/A
  • VALU $19.45
  • Revenue Growth
  • PSNL 24.05
  • VALU N/A
  • 52 Week Low
  • PSNL $1.12
  • VALU $36.00
  • 52 Week High
  • PSNL $7.20
  • VALU $57.68
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 45.39
  • VALU 31.00
  • Support Level
  • PSNL $5.22
  • VALU $48.00
  • Resistance Level
  • PSNL $5.50
  • VALU $49.82
  • Average True Range (ATR)
  • PSNL 0.57
  • VALU 1.20
  • MACD
  • PSNL -0.18
  • VALU -0.69
  • Stochastic Oscillator
  • PSNL 8.33
  • VALU 1.77

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About VALU Value Line Inc.

Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.

Share on Social Networks: